The U.S. Food and Drug Administration (FDA) has asked for a voluntary recall of valsartan (which was formerly known as Diovan before the drug changed to generic formulation).   Valsartan is used to treat high blood pressure and heart failure.

The recall is not due to the valsartan itself raising a concern for cancer risk.

This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products.  It is important to note that not all products containing valsartan are being recalled.  NDMA is listed as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.  The contamination of the generic valsartan medications with NDMA was unexpected and believed to be due to changes in the way the medi...

February 15, 2017

Please click here for Dr. Champion's latest Wellness Wednesday episode on WRBL.

Heart disease is the leading killer of women in America. In the United States, 1 in 4 women dies from heart disease. Each year more women die of heart disease than men, yet heart disease and related risk factors are often missed in women. Symptoms of coronary artery disease and heart attack, for example, are often different in women than their male counterparts. Women are also less likely to receive optimal treatment for certain heart conditions.  Unfortunately, many women notice warning signs but ignore them. Participants in an American Heart Association study said they hesitated to call for help because they were uncertain, thought they could treat themselves or were simply too busy with fami...

Please reload

© 2016 Proudly created by Naartjie Multimedia